Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Singapore-based Biofourmis, which claims to be the world’s first personalised physiological data analytics firm, has closed a US$ 1 million round, that was led by South African healthcare professional services provider SpesNet and Eden Strategy.  The round also saw participation from other angel investors in the healthcare space.